22 March 2017 - Deborah Wilkes
Archived
Stada Arzneimittel says existing takeover bids "do not yet reflect" the company's fundamental value, and is encouraging bidders to increase their offers. Meanwhile, the company has postponed its annual results press conference by six days due to a "reassessment of a transaction".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.